Fig. 4From: Anti-inflammatory and immune-enhancing effects of enzyme-treated royal jellyEffect of ERJ on NK cell activity. (A) In vitro NK cell activity. ERJ enzyme-treated royal jelly, RJ non-enzyme-treated royal jelly. Data are expressed as mean ± SE (n = 3). (B) In vivo NK cell activity. ERJ enzyme-treated royal jelly, RJ non-enzyme-treated royal jelly. Data are expressed as mean ± SE (n = 10). **p < 0.01; ***p < 0.001, compared with vehicleBack to article page